Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

RAYMED LABS vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 RAYMED LABS   TEVA PHARMA
EQUITY SHARE DATA
    RAYMED LABS
Mar-23
TEVA PHARMA
Dec-13
RAYMED LABS/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs23,486-   
Low Rs13,028-   
Sales per share (Unadj.) Rs02,000.5-  
Earnings per share (Unadj.) Rs-0.4125.0-  
Cash flow per share (Unadj.) Rs-0.4286.7-  
Dividends per share (Unadj.) Rs0109.40-  
Avg Dividend yield %03.4 0.0%  
Book value per share (Unadj.) Rs-5.42,222.2-  
Shares outstanding (eoy) m4.27848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x01.6-  
Avg P/E ratio x-4.426.1 -16.9%  
P/CF ratio (eoy) x-4.611.4 -40.1%  
Price / Book Value ratio x-0.31.5 -22.3%  
Dividend payout %087.5 -0.0%   
Avg Mkt Cap Rs m82,761,843 0.0%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m00-   
Avg. sales/employee Rs Th037,744.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,357.9-  
INCOME DATA
Net Sales Rs m01,696,422 0.0%  
Other income Rs m00-   
Total revenues Rs m01,696,422 0.0%   
Gross profit Rs m-2464,566 -0.0%  
Depreciation Rs m0137,123 0.0%   
Interest Rs m033,320 0.0%   
Profit before tax Rs m-2294,122 -0.0%   
Minority Interest Rs m01,336 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-193,075 -0.0%   
Tax Rs m0-3,591 -0.0%   
Profit after tax Rs m-2105,974 -0.0%  
Gross profit margin %027.4- 
Effective tax rate %0-1.2 0.0%   
Net profit margin %06.2- 
BALANCE SHEET DATA
Current assets Rs m01,145,757 0.0%   
Current liabilities Rs m1999,197 0.0%   
Net working cap to sales %08.6- 
Current ratio x0.11.1 4.8%  
Inventory Days Days091- 
Debtors Days Days096- 
Net fixed assets Rs m2554,089 0.0%   
Share capital Rs m434,176 1.0%   
"Free" reserves Rs m-660-   
Net worth Rs m-231,884,403 -0.0%   
Long term debt Rs m0867,418 0.0%   
Total assets Rs m23,876,868 0.0%  
Interest coverage x09.8-  
Debt to equity ratio x00.5 -0.0%  
Sales to assets ratio x00.4 0.0%   
Return on assets %-109.53.6 -3,047.1%  
Return on equity %7.45.6 131.8%  
Return on capital %7.44.9 150.2%  
Exports to sales %00-  
Imports to sales %00-  
Net fx Rs m00-   
CASH FLOW
From Operations Rs m-2270,322 -0.0%  
From Investments Rs m2-95,786 -0.0%  
From Financial Activity Rs mNA-324,269 -0.0%  
Net Cashflow Rs m0-149,733 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.51 Rs / USD

Compare RAYMED LABS With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare RAYMED LABS With: EARUM PHARMACEUTICALS  ZENITH DRUGS LTD.  ZENOTECH LABS  AMBALAL SARABHAI  DISHMAN PHARMA  



Today's Market

Gift Nifty Down 342 Points | Tata Motors to Make JLR Cars in Tamil Nadu | Kronox Lab Sciences to Launch IPO | Top Buzzing Stocks Today Gift Nifty Down 342 Points | Tata Motors to Make JLR Cars in Tamil Nadu | Kronox Lab Sciences to Launch IPO | Top Buzzing Stocks Today(Pre-Open)

It was indeed a volatile trading session for Indian share markets yesterday.